G43
Migraine
Migraine is a chronic neurological disorder characterized by recurrent episodes of moderate-to-severe headache that are typically unilateral, pulsating, and aggravated by routine physical activity. The pathophysiology is complex, involving the activation of the trigeminovascular system, the release of calcitonin gene-related peptide (CGRP), and cortical spreading depression (CSD), which is believed to cause the migraine aura. Migraine is more than just a headache; it is a systemic condition often preceded by a prodromal phase (premonitory symptoms like yawning or neck stiffness) and followed by a postdrome (the "migraine hangover"). It affects approximately 12% of the population, with a significantly higher prevalence in women due to hormonal influences. Classification is primarily divided between migraine without aura and migraine with aura, though several subtypes and migraine-associated periodic syndromes exist. Management involves both acute abortive treatments (triptans, NSAIDs, gepants) and preventive strategies (beta-blockers, CGRP monoclonal antibodies, anticonvulsants).
Clinical Symptoms
- Unilateral, throbbing, or pulsating headache
- Nausea and vomiting
- Photophobia (light sensitivity)
- Phonophobia (sound sensitivity)
- Osmophobia (odor sensitivity)
- Visual aura (scotomas, flashing lights, or zigzag lines)
- Sensory aura (paresthesias or tingling)
- Speech or language disturbances (dysphasic aura)
- Neck stiffness and pain
- Fatigue and irritability
- Cognitive fog or difficulty concentrating
- Dizziness or vertigo
- Prodromal yawning and food cravings
Common Causes
- Genetic predisposition (polygenic inheritance)
- Activation of the trigeminovascular system
- Release of vasoactive neuropeptides like CGRP and substance P
- Cortical spreading depression (CSD)
- Hormonal fluctuations (especially estrogen withdrawal in menstrual migraine)
- Sleep disturbances (insomnia or oversleeping)
- Stress and emotional triggers
- Dietary triggers (nitrates, MSG, tyramine, or aged cheeses)
- Environmental factors (bright lights, weather changes, strong odors)
- Caffeine overuse or withdrawal
Documentation & Coding Tips
Explicitly state the presence or absence of aura to determine the 4th character specificity.
Example: Patient presents for follow-up of recurring headaches. She describes a 15-minute visual prodrome consisting of shimmering lights and jagged lines followed by a severe throbbing right-sided hemicranial pain. Diagnosis: Migraine with aura, not intractable, without status migrainosus (G43.109). Management includes daily prophylaxis with topiramate and sumatriptan for acute attacks.
Billing Focus: Documentation of aura (visual, sensory, or speech disturbances) is required to distinguish G43.1 (with aura) from G43.0 (without aura).
Define intractability based on the patient's response to multiple medication classes.
Example: Assessment: Chronic migraine without aura. Patient has failed three different classes of prophylactic agents (Beta-blockers, TCAs, and Antiepileptics) and continues to experience 18 headache days per month. The condition is documented as intractable (G43.719) for coding purposes.
Billing Focus: The term intractable must be explicitly used by the provider to assign the corresponding character (e.g., G43.x1x). Synonyms like pharmacoresistant or refractory are acceptable clinically but must map to intractable.
Distinguish between episodic migraine and chronic migraine based on the frequency of attacks.
Example: Patient reports a total of 17 headache days per month over the last quarter, with at least 9 of those days meeting full criteria for migraine. This meets the clinical threshold for chronic migraine without aura, not intractable, without status migrainosus (G43.709).
Billing Focus: Chronic migraine (G43.7) requires documentation of 15 or more headache days per month for at least 3 months, with migraine features on at least 8 of those days.
Verify the presence of status migrainosus for acute exacerbations lasting longer than 72 hours.
Example: Patient presents to the clinic with a debilitating migraine that has persisted for 96 hours despite home use of naratriptan and ibuprofen. Physical exam shows photophobia and phonophobia. Diagnosed as migraine with aura, not intractable, with status migrainosus (G43.101).
Billing Focus: Status migrainosus is identified by the 6th character (1). Documentation must confirm the headache duration exceeded 72 hours.
Document specific migraine variants such as hemiplegic or ophthalmoplegic for maximum specificity.
Example: Evaluation of 24-year-old male with recurrent attacks of unilateral headache accompanied by reversible motor weakness on the left side. History of similar episodes in father. Diagnosed as familial hemiplegic migraine (G43.409).
Billing Focus: Specific variants (hemiplegic, persistent aura without infarction) map to specific codes in the G43.4, G43.5, and G43.6 ranges.
Relevant CPT Codes
-
99214 - Office or other outpatient visit for the evaluation and management of an established patient
Typically used for managing chronic migraine with medication adjustments or assessing intractable status.
-
99213 - Office or other outpatient visit for the evaluation and management of an established patient
Used for stable episodic migraine follow-ups with no major medication changes.
-
99204 - Office or other outpatient visit for the evaluation and management of a new patient
Appropriate for initial consultation for new-onset severe headaches requiring extensive workup.
-
64615 - Chemodenervation of muscle(s) innervated by facial, trigeminal, cervical spinal and accessory nerves, bilateral
Specific procedure for patients with chronic migraine (G43.7) failing oral therapies.
-
64405 - Injection, anesthetic agent; greater occipital nerve
Commonly used in acute settings or office-based rescue therapy for migraine.
-
96372 - Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular
Standard administration code for acute migraine rescue in the office.
-
99215 - Office or other outpatient visit for the evaluation and management of an established patient
Used for patients with complex comorbidities or those requiring hospitalization for status migrainosus.
-
20550 - Injection(s); single tendon sheath or ligament, aponeurosis
Used when migraine is triggered or exacerbated by myofascial pain components.
-
95816 - Electroencephalogram (EEG); including recording, interpretation and report
Ordered when migraine with aura needs to be differentiated from seizure activity.
-
70551 - Magnetic resonance (e.g., proton) imaging, brain; without contrast material
Standard imaging to rule out secondary causes of headache (tumors, lesions).
Related Diagnoses
- G43.009 - Migraine without aura, not intractable, without status migrainosus
- G43.109 - Migraine with aura, not intractable, without status migrainosus
- G43.711 - Chronic migraine without aura, intractable, with status migrainosus
- G44.209 - Tension-type headache, unspecified, not intractable
- G44.009 - Cluster headache syndrome, unspecified, not intractable
- G43.809 - Other migraine, not intractable, without status migrainosus
- G43.C0 - Periodic syndromes in child or adult which are commonly precursors of migraine, not intractable
- R51.9 - Headache, unspecified
- G43.A0 - Cyclical vomiting, not intractable
- G43.509 - Persistent aura without infarction, not intractable, without status migrainosus
- I67.848 - Other cerebrovascular disease
- G43.401 - Hemiplegic migraine, not intractable, with status migrainosus